Citation Impact
Citing Papers
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
To Interfere and to Anti-interfere: The Interplay Between Hepatitis C Virus and Interferon
2002
Dengue Virus Type 2 Antagonizes IFN-α but Not IFN-γ Antiviral Effect via Down-Regulating Tyk2-STAT Signaling in the Human Dendritic Cell
2005
The DNA-damage response in human biology and disease
2009 StandoutNature
Chemosensitivity linked to p73 function
2003 StandoutNobel
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
1997 Standout
Mdm2 promotes the rapid degradation of p53
1997 StandoutNature
p53 in growth control and neoplasia
1996
How Hepatitis C Virus Counteracts the Interferon Response: The Jury Is Still out on NS5A
2001
Global Cancer Statistics, 2002
2005 Standout
Papillomavirus infections — a major cause of human cancers
1996 StandoutNobel
Immune responses to human papillomavirus
2005
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Role of the SCFSkp2 Ubiquitin Ligase in the Degradation of p21Cip1 in S Phase
2003 StandoutNobel
A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
2010 Standout
DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2
1997 Standout
p53 codon 72 polymorphism and its association with bladder cancer
2002
Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality
2003
Basic mechanisms of high‐risk human papillomavirus‐induced carcinogenesis: Roles of E6 and E7 proteins
2007
Loss of Net as Repressor Leads to Constitutive Increased c-fos Transcription in Cervical Cancer Cells
2004 StandoutNobel
Head and neck cancer
2008 Standout
Prevalence of HPV Infection Among Females in the United States
2007 Standout
The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2
1997
The role of the E6-p53 interaction in the molecular pathogenesis of HPV
1999
Serum anti-p53 autoantibodies from patients with idiopathic pulmonary fibrosis associated with lung cancer
2000
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
1998 StandoutNature
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Skin Cancers after Organ Transplantation
2003 Standout
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP
2007
Blinded by the Light: The Growing Complexity of p53
2009 Standout
The Human Papillomavirus E7 Protein Is Able to Inhibit the Antiviral and Anti-growth Functions of Interferon-α
2000
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Polymorphism at Codon 72 of the p53 Gene Is Not associated With Endometriosis in a Japanese Population
2004
The causal relation between human papillomavirus and cervical cancer
2002 Standout
Human papillomavirus and cervical cancer
2007 Standout
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
2007 Standout
Multifactorial analysis of p53 alteration in human cancer: A review
1994
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
Polymorphisms in the p53 pathway
2006
VIRUSES AND THE TYPE I INTERFERON ANTIVIRAL SYSTEM: INDUCTION AND EVASION
2002
Hypersusceptibility to Vesicular Stomatitis Virus Infection in Dicer1-Deficient Mice Is Due to Impaired miR24 and miR93 Expression
2007 StandoutNobel
Disruption of CD40–CD40 Ligand Interactions Results in an Enhanced Susceptibility to Leishmania amazonensis Infection
1996
Endometriosis
2004 Standout
TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes
2007
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Idiopathic pulmonary fibrosis
2011 Standout
The NS5A Protein of Hepatitis C Virus Is a Zinc Metalloprotein
2004 StandoutNobel
Human Papillomavirus DNA and p53 Polymorphisms in Squamous Cell Carcinomas From Fanconi Anemia Patients
2003
The genetics of the p53 pathway, apoptosis and cancer therapy
2008
Evasion of innate immunity by parasitic protozoa
2002
An Alternative Form of Replication Protein A Expressed in Normal Human Tissues Supports DNA Repair
2009 StandoutNobel
Recent advances in vaccines for leishmaniasis
2004
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
2003 Standout
New therapeutic strategies for hepatitis C
2002 StandoutNobel
Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting
2005 StandoutNobel
Relationship Between p53 Codon 72 Polymorphism and Susceptibility to Sunburn and Skin Cancer
2002
Specific Inhibition of Type I Interferon Signal Transduction by Respiratory Syncytial Virus
2004
Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells
2001 StandoutNobel
Ubiquitination of p53 and p21 Is Differentially Affected by Ionizing and UV Radiation
1997
Preferential retention of codon 72 arginine p53 in squamous cell carcinomas of the vulva occurs in cancers positive and negative for human papillomavirus.
2000 StandoutNobel
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
Autoimmunity to the M(r) 32,000 subunit of replication protein A in breast cancer.
2002
Blocking of Interferon-Induced Jak-Stat Signaling by Japanese Encephalitis Virus NS5 through a Protein Tyrosine Phosphatase-Mediated Mechanism
2006
TRANCE, a Tumor Necrosis Factor Family Member Critical for CD40 Ligand–independent T Helper Cell Activation
1999 StandoutNobel
Increased T Cell Autoreactivity in the Absence of CD40-CD40 Ligand Interactions: A Role of CD40 in Regulatory T Cell Development
2001 StandoutNobel
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
2007 Standout
MDM2 Suppresses p73 Function without Promoting p73 Degradation
1999 StandoutNobel
Advances in leishmaniasis
2005 Standout
Herpes Simplex Virus 1 Gene Products Occlude the Interferon Signaling Pathway at Multiple Sites
2004
HPV: from infection to cancer
2007
A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens
1998
Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication
2002 StandoutNobel
Disturbance of Tumor Necrosis Factor Alpha-Mediated Beta Interferon Signaling in Cervical Carcinoma Cells
2002 StandoutNobel
The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography.
2002
Control of interferon signaling in human papillomavirus infection
2001
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Inhibition of Interferon-Stimulated JAK-STAT Signaling by a Tick-Borne Flavivirus and Identification of NS5 as an Interferon Antagonist
2005
General Suppression of Macrophage Gene Expression DuringLeishmania donovaniInfection
2001
High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6
2001 StandoutNobel
Blocking of the Alpha Interferon-Induced Jak-Stat Signaling Pathway by Japanese Encephalitis Virus Infection
2004
Papillomavirus Type 16 Oncogenes Downregulate Expression of Interferon-Responsive Genes and Upregulate Proliferation-Associated and NF-κB-Responsive Genes in Cervical Keratinocytes
2001
c-Abl Regulates p53 Levels under Normal and Stress Conditions by Preventing Its Nuclear Export and Ubiquitination
2001 StandoutNobel
Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens.
2003
THE UBIQUITIN SYSTEM
1998 StandoutNobel
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers
2000
Gene Amplification in a p53-Deficient Cell Line Requires Cell Cycle Progression under Conditions That Generate DNA Breakage
1998
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
2005 StandoutNobel
Works of Sylvie Labrecque being referenced
The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α
1999
Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response
2001
DNA damage induced p53 mediated transcription is inhibited by human papillomavirus type 18 E6.
1994
Alteration of Leishmania donovani infection levels by selective impairment of macrophage signal transduction.
1993
Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically
1999
Viability of wild type p53-containing and p53-deficient tumor cells following anticancer treatment: the use of human papillomavirus E6 to target p53.
1995
Analysis of the anti-p53 antibody response in cancer patients.
1993
p53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation
2000